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Abstract: Withania somnifera (Ashwagandha) root extract possesses a broad range of pharmacological activities. The aim of 
current study was to explore the impact of The Trivedi Effect® - Energy of Consciousness Healing Treatment (Biofield Energy 
Healing Treatment) on the physical, spectroscopic, and thermal properties of ashwagandha root extract using PXRD, PSD, FT-
IR, UV-vis spectroscopy, TGA, and DSC analysis. Ashwagandha root extract was divided into two parts. One part was 
denoted as the control, while the other part was defined as The Trivedi Effect® - Biofield Energy Treated sample, which 
received The Trivedi Effect® Treatment remotely from eighteen renowned Biofield Energy Healers. The PXRD analysis 
exhibited that both the control and The Trivedi Effect® - Biofield Energy Treated samples were amorphous in nature. The 
particle size values at d10 and d50 of the treated sample were decreased by 4.66% and 6.02% and at d90 slightly increased by 
0.99% compared with the control sample. The average surface area of the treated (0.130 m2/g) sample was increased by 4.84% 
compared with the control (0.124 m2/g) sample. The FT-IR results suggested that the force constant of O-H (stretching), and 
C-O (stretching) functional groups of the treated sample were reduced compared with the control sample. The UV-vis analysis 
revealed that the wavelength for the maximum absorbance of the control and treated samples were at 205.4 nm and 205.6 nm, 
respectively. The TGA thermograms exhibited three steps of the degradation process, and the total weight loss of the treated 
(86.45%) sample was increased by 1.44% compared with the control (85.22%) sample. The DSC analysis revealed that melting 
point of the treated (201.67°C) sample was reduced by 0.87% compared with the control (203.43°C) sample. The latent heat of 
fusion of the treated (6.77 J/g) sample was significantly decreased by 21.82% compared to the control (8.67 J/g) sample. Hence, 
the treated sample would be more advantageous for the better therapeutic responses compared to the control sample. These 
findings suggest that The Trivedi Effect® - Energy of Consciousness Healing Treatment might have the astounding capacity to 
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enhance the solubility, dissolution, absorption, and bioavailability of ashwagandha root extract in various forms of 
pharmaceutical/nutraceutical formulations by modifying its particle size and surface area. Thus, The Trivedi Effect® - Energy 
of Consciousness Healing Treated ashwagandha root extract might provide better therapeutic response against inflammatory 
diseases, immunological disorders, stress, arthritis, cancer, diabetes, sexual disorders, aging and other chronic infections. 
Keywords: Withania somnifera, Biofield Energy Healing Treatment, Biofield Energy Healers,  
Consciousness Energy Healing Treatment, The Trivedi Effect®, PXRD, Particle Size, TGA, DSC 
 
1. Introduction 
The importance of the herbal medicines in the prevention 
and treatment of the various diseases has been increased day-
by-day throughout the world due to its impressive therapeutic 
effects and fewer side effects compared to the modern 
medicines [1]. The roots of Withania somnifera (W. 
somnifera) (L.) Dunal (Family- Solanaceae) - a vital 
Rasayana herb is traditionally known as ‘Ashwagandha’ or 
winter cherry. In Ayurveda, it is called as ‘Indian ginseng’. 
Ashwagandha is widely used in the most of the Indian herbal 
drugs and nutraceuticals for the treatment of various diseases 
include nervous and sexual disorders, infectious diseases, 
diabetes, cancer, ulcer, immunological disorders, stress, 
arthritis, etc. From the ancient time, it is used as a tonic to 
arrest the ageing process, rejuvenate the body and boost the 
defence against infectious disorders and also promote the 
longevity [2-11]. Ashwagandha root extract contains a wide 
array of nutrients and phytochemicals. Hence, it is used as a 
dietary supplement for the health restoration [3]. The major 
active phytoconstituents of ashwagandha root extract are 
highly oxygenated withanolides. Withanolides have C28 
steroidal nucleus with C9 side chain, having a six membered 
lactone ring (Figure 1). The oxidation at various sites of the 
skeleton is responsible for the structural deviations in 
different classes of withanolides [11-14]. 
 
Figure 1. The basic skeleton of withanolide. 
Literatures reported that withanolides such as withaferin A, 
withanolide D, withanolide E, etc. possesses various 
pharmacological activities include antioxidant, anticancer, 
immunomodulating, neuroprotective, antiepileptic, 
antibacterial, adaptogenic, spermatogenic, antidepressant, 
antianxiety, hepatoprotective, anti-inflammatory, antiarthritic, 
antimicrobial, hypoglycemic, hypolipidemic, aphrodisiac, 
antiulcer, radiosensitizing, etc. [11, 14-19]. Therefore, a new 
proprietary herbomineral formulation was formulated that 
consisted of the herbal product like ashwagandha root extract 
along with minerals such as zinc, magnesium, and selenium. 
This herbomineral formulation is designed as nutraceutical 
supplement and can be used for the prevention and treatment 
of various human disorders. 
Every living organism preserves some kind of unique 
quality, an élan vital or vital force, which contributes the 
‘life’. From the ancient-time, this living force is known as 
Prana by the Hindus, qi or chi by the Chinese, and ki by the 
Japanese and is usually believed to create the source of life 
that is related with soul, spirit, and mind. Now-a-days, this 
hypothetical vital force is considered as the Bioenergetics 
Field. This energy field is a dynamic electromagnetic field 
existing surround of the human body. The Biofield Energy is 
infinite and paradimensional. It can freely flow between the 
human and the environment that leads to the continuous 
movement or matter of energy [20, 21]. Thus, the human can 
harness energy from the earth, the “universal energy field” 
and transmit it to any living or nonliving object (s) around 
the globe. The objects always receive the energy and respond 
in a useful way. This process is known as Biofield Energy 
Healing Treatment [22, 23]. Biofield (Putative Energy Fields) 
based Energy Therapies are used worldwide to promote 
health and healing [24]. The National Center of 
Complementary and Integrative Health (NCCIH) has been 
recognized and accepted Biofield Energy Healing as a 
Complementary and Alternative Medicine (CAM) health care 
approach in addition to other therapies, medicines and 
practices such as natural products, deep breathing, yoga, Tai 
Chi, Qi Gong, chiropractic/osteopathic manipulation, 
meditation, massage, special diets, homeopathy, progressive 
relaxation, guided imagery, acupressure, acupuncture, 
relaxation techniques, hypnotherapy, healing touch, 
movement therapy, pilates, rolfing structural integration, 
mindfulness, Ayurvedic medicine, traditional Chinese herbs 
and medicines, naturopathy, essential oils, aromatherapy, 
Reiki, cranial sacral therapy and applied prayer (as is 
common in all religions, like Christianity, Hinduism, 
Buddhism and Judaism) [25]. The Biofield Energy Treatment 
(The Trivedi Effect®) has been extensively studied with 
significant outcomes in many scientific fields such as cancer 
research [26], altered antimicrobial sensitivity of pathogenic 
microbes in microbiology [27-29], biotechnology [30, 31], 
genetics [32, 33], changing the structure of the atom in 
relation to the various metals, ceramics, polymers and 
chemicals materials science [34-36], altered physical and 
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chemical properties of pharmaceuticals [37, 38], 
nutraceuticals [39, 40], organic compounds [41-43], and 
improved overall growth and yield of plants in agricultural 
science [44, 45]. Herbal extracts and herbal drugs despite of 
their outstanding in vitro results exhibited poor or negligible 
in vivo activity, because of their reduced lipid solubility or 
improper molecular size, causing deprived absorption and 
thus poor bioavailability [1]. According to the recent study 
on the bioavailability of major withanolides of W. somnifera, 
Devkar et al. demonstrated that the nonpolar and low 
molecular weight withanolides were highly permeable, 
whereas the high glycosylated and polar withanolides 
displayed low permeability in their in vitro absorption model 
system [46]. As ashwagandha root extract has the 
outstanding nutritional and medicinal values, researchers are 
still working on to find out an optimal dosage range for 
reproducing the desired effects in human as well as to 
determine the safe, non-toxic, and effective dosage form [7]. 
The physicochemical properties such as particle size, 
crystalline structure, crystallite size, surface area, etc. and 
thermal properties of a drug have a vital role in 
bioavailability as well as the stability of the drug during 
processing, formulation, storage, and packaging [47, 48]. 
Biofield Energy Treatment (The Trivedi Effect®) has been 
reported to change the particle size, specific surface area, 
crystalline, chemical and thermal behaviour of an atom/ion 
through the possible mediation of neutrinos [49]. By 
considering all these aspects, the objective of the current 
study was to examine whether the Biofield Energy Treatment 
can change the physical, structural, and thermal properties in 
such a way that might be assisting in the improvement of the 
solubility, absorption and also help in designing of any 
suitable pharmaceutical formulation. The physical, 
spectroscopic, and thermal properties of both the control and 
Biofield Energy Treated ashwagandha root extracts were 
evaluated using various analytical techniques include Fourier 
transform infrared (FT-IR) spectrometry, ultraviolet-visible 
(UV-vis) spectroscopy, powder X-ray diffraction (PXRD), 
particle size distribution analysis (PSD), thermogravimetric 
analysis (TGA), and differential scanning calorimetry (DSC). 
2. Materials and Methods 
2.1. Chemicals and Reagents 
Withania somnifera (ashwagandha) hydroalcoholic root 
extract was purchased from Sanat Product Ltd, India. All the 
other chemicals used in this experiment were analytical grade 
procured from the local vendors. 
2.2. Energy of Consciousness Healing Treatment Strategy 
Ashwagandha root extract powder was one of the components 
of the new proprietary herbomineral formulation, developed by 
our research team, and it was used per se as the test compound 
for the current study. The test compound was divided into two 
parts, one part of the test compound was treated with The 
Trivedi Effect® - Energy of Consciousness Healing Treatment 
by renowned Biofield Energy Healers and defined as The 
Trivedi Effect® sample, while the second part of the test 
compound did not receive any sort of treatment and defined as 
untreated or control ashwagandha root extract sample. The 
group of eighteen Biofield Energy Healers who participated in 
this study performed The Trivedi Effect® - Energy of 
Consciousness Healing Treatment remotely to the test 
compound. Eleven of the Biofield Energy Healers were located 
in the U. S. A., four in Canada, one in Ireland, one in the United 
Kingdom, and one in Russia performed The Trivedi Effect® on 
the test compound that was located in the research laboratory of 
GVK Biosciences Pvt. Ltd., Hyderabad, India. This Biofield 
Energy Treatment was provided for 5 minutes through Healer’s 
Unique Energy Transmission process remotely to the test 
compound under the laboratory conditions. None of the Biofield 
Energy Healers in this study visited the laboratory in person, nor 
had any contact with the compounds. Similarly, the control 
compound was subjected to “sham” healers for 5 minutes, under 
the same laboratory conditions. The sham healer did not have 
any knowledge about The Trivedi Effect® - Biofield Energy 
Treatment. After that, the treated and untreated samples were 
kept in similar sealed conditions and were characterized 
thoroughly by PXRD, PSD, FT-IR, UV-visible spectroscopy, 
TGA, and DSC analysis. 
2.3. Characterization 
2.3.1. Powder X-Ray Diffraction (PXRD) Analysis 
The PXRD analysis was accomplished on PANalytical X’pert 
Pro powder X-ray diffractometer system. The X-ray of 
wavelength 1.54056 Å was used. The data was collected in the 
form of a chart of the Bragg angle (2θ) vs. intensity, and a 
detailed table containing information on peak intensity counts, d 
value (Å), relative intensity (%), full width half maximum 
(FWHM) (θ°). From the XRD results, the crystallite size (G) 
was calculated using X’pert data collector and X’pert high score 
plus processing software. A total of 500.19 mg of control and 
500.23 mg of the treated samples individually used for the 
analysis and prepared by back loading technique using the 
sample preparation kit. The sample was spread on the holder 
ring in sufficient quantity to fill the ring cavity. It was then 
pressed down using powder press block and scrap the powder 
that was in surplus using a glass slide to get densely packed 
specimen. Consequently, the bottom plate was placed onto the 
holder ring and clamp in position. The sample holder was then 
removed from the sample preparation table by turning it upside 
down. A smooth surface of the sample was obtained to ensure 
the optimum results. 
2.3.2. Particle Size Distribution (PSD) Analysis 
The average particle size and particle size distribution 
were analyzed using Malvern Mastersizer 2000, UK with a 
detection range between 0.01 µm to 3000 µm. The sample 
unit was filled with the dispersant medium and operated the 
stirrer at 2500 rpm. Alignment of the optics was done and 
the background measurement was taken. After the 
background measurement, the sample was added in to the 
sample unit with constant monitoring the obscuration and 
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stopped the addition of sample when the obscuration 
reached in between 15% to 20%. When the obscuration was 
stable, the measurement was taken twice, and the average 
was taken of two measurements. The average histogram of 
the two measurements was recorded. Along with histogram, 
the data was presented in a table format which includes 
particle size (µm). Also, the values at below 10% level (d10), 
50% level (d50), and 90% level (d90) were calculated from 
the histogram, and the calculations such as surface area 
(m2/g) were done by using software Mastersizer 2000. 
Percent change in particle size (d) for at below 10% level 
(d10), 50% level (d50), and 90% level (d90) was calculated 
using following equation 1: 
%	change	in	particle	size    100	  (1) 
Where, dControl and dTreated are the particle size (µm) for at 
below 10% level (d10), 50% level (d50), and 90% level (d90) 
of the control and treated samples, respectively. 
Percent change in surface area (S) was calculated using 
following equation 2: 
%	change	in	surface	area  $$$  100  (2) 
Where, SControl and STreated are the surface area of the 
control and treated samples, respectively. 
2.3.3. Fourier Transform Infrared (FT-IR) Spectroscopy 
FT-IR spectroscopy of ashwagandha root extract was 
performed on Spectrum two (Perkin Elmer, USA) Fourier 
transform infrared spectrometer with the frequency array of 
400-4000 cm-1 by using pressed KBr disk technique. 
2.3.4. Ultra Violet-Visible Spectroscopy (UV-Vis) Analysis 
The UV-Vis spectral analysis was carried out using 
Shimadzu UV-2450 with UV Probe, Japan. The spectrum 
was recorded using 1. cm quartz cell that has a slit width of 
1.0 nm. The wavelength ranges chosen for recording the 
spectra was 190-800 nm. The absorbance spectra (in the 
range of 0.2 to 0.9) and the wavelength of maximum 
absorbance (λmax) were recorded. 
2.3.5. Thermal Gravimetric Analysis (TGA) 
The TGA analysis was performed using Instrument TGA 
Q50 (TA Instruments, USA) at a heating rate of 10°C/min 
from room temperature i.e. 30°C to 900°C under nitrogen 
atmosphere. A total of 11.86 mg of sample was used for the 
analysis and was taken on the platinum pan. In TGA, the 
weight loss for each step was recorded in grams as well as in 
percent loss with respect to the initial weight. Also, the onset, 
endset, and peak temperature for each step were recorded in 
TGA. Percent change in weight loss (W) was calculated 
using following equation 3: 
%	change	in	weight	loss  '	'	'	  100  (3) 
Where, WControl and WTreated are the weight loss of the 
control and Biofield Energy Treated samples, respectively. 
2.3.6. Differential Scanning Calorimetry (DSC)
 
Analysis was performed using the DSC Q20 (TA 
Instruments, USA) differential scanning calorimeter. A total 
of 8.10 mg sample was weighed and sealed in aluminium pan 
and equilibrated at 25°C and heated up to 450°C at the 
heating rate of 10°C/min under nitrogen gas as purge 
atmosphere with the flow rate of 50 mL/min. The value for 
onset, endset, peak temperature, peak height (mJ or mW), 
peak area, and change in heat (J/g) for each peak were 
recorded. Percent change in melting point (T) was calculated 
using following equation 4: 
%	change	in	melting	point  )))  100   (4) 
Where, TControl and TTreated are the melting point of the 
control and treated samples, respectively. 
Percent change in latent heat of fusion (∆H) was calculated 
using following equation 5: 
%	change	in	Latent	heat	of	fusion  +,+,+,  100	   (5) 
Where, ∆HControl and ∆HTreated are the latent heat of fusion 
of the control and treated samples, respectively. 
3. Results and Discussions 
3.1. Powder X-ray Diffraction (PXRD) Analysis 
The powder X-ray diffraction study was conducted to 
explore the crystalline pattern of the control and treated 
samples of ashwagandha root extract (Figure 2). The PXRD 
diffractograms of the control and treated samples of 
ashwagandha did not contribute any diffraction peaks, 
indicated that both the samples were amorphous in nature. 
The X-rays of the amorphous compound scatter in many 
directions leading to a large bump distribute in a wide range 
(2θ) instead of high concentration narrower peaks [50, 51]. 
 
Figure 2. PXRD diffractograms of the control and Biofield Energy Treated W. somnifera (ashwagandha) root extract. 
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3.2. Particle Size Distribution (PSD) Analysis 
The particle size (d10, d50 and d90) of the control and treated 
samples were investigated, and the results are shown in Table 
1. The particle size of the treated sample showed at d10 and 
d50 was decreased by 4.66% and 6.02%, respectively 
compared with the control sample. The particle size of the 
treated sample at d90 was increased slightly by 0.99% 
compared with the control sample. The surface area of the 
treated sample (0.130 m2/g) was increased by 4.84% 
compared with the control sample (0.124 m2/g) (Table 1). 
The reduction in particle size leads to the increase in surface 
area in the treated sample. The results revealed that there 
might be an effect of the high energy milling induced by The 
Trivedi Effect® treatment to ashwagandha root extract. The 
decrease in the particle size and increase in the surface area 
has the significant influence on the increase in drug release, 
dissolution, absorption, drug action and dose uniformity of 
any substance in various drug delivery system [52]. 
Table 1. Particle size data (d10, d50 and d90) and surface area of the control 
and Biofield Energy Treated W. somnifera (ashwagandha) root extract.  
Test Item d10 (µm) d50 (µm) d90 (µm) Surface area (m
2/g) 
Control 40.480 162.141 370.665 0.124 
Biofield Energy 
Treated 
38.595 152.385 374.351 0.130 
% changea -4.66 -6.02 0.99 4.84 
a denotes the percentage change in the particle size data (d10, d50, and d90) and 
surface area of Biofield Energy Treated sample with respect to the control 
sample. 
3.3. Fourier Transform Infrared (FT-IR) Spectroscopy 
The FT-IR spectra displayed the prominent peaks 
correspond to the different functional groups of 
phytoconstituents present in both the control and treated 
ashwagandha root extract (Figure 3). The wavenumber of the 
absorbance (ν) of a diatomic can be calculated from the 
Hooke’s law (Eq.6). The following equation gives the 
frequency of radiation (IR) that a molecule absorb and gives 
the frequency of vibration of the normal mode being excited 
by that radiation [53]. 
-  ./0123	(56758)56	58	 	                     (6) 
Where, v = vibrational frequency (cm-1), c = the velocity 
of light (cm/s), m1 and m2 = the mass of atoms 1 and 2, 
respectively in g, f = the force constant of the bond 
(dyne/cm). 
From the above equation 6, it has been shown that if other 
factors remain constant, the vibrational frequency 
(wavenumber) is directly proportional to the force constant. 
The FT-IR spectra (Figure 3) indicated the O-H stretching 
of the treated sample (3367 cm-1) was shifted downward 
compared with the control sample (3392 cm-1) (Table 2, entry 
1). The broad peak at 3600-3200 cm-1 may be due to the O-H 
functional group of the phytoconstituents present in the 
ashwagandha root extract [10, 53, 54]. Similarly, the C-O 
stretching of the treated sample (1268 cm-1) was shifted 
downward compared with the control sample (1291 cm-1). 
The results indicated that the force constant of the O-H 
functional group of the treated sample was reduced compared 
with the control sample. The FT-IR exhibited similar 
aliphatic C-H stretching at 2927-2856 cm-1, and C=O 
stretching at 1684 cm-1 for aldehyde/ketonic functional group 
in both the control and treated samples (Table 2, entry 2 and 
3). The C=C (aromatic bending), C-H (aromatic and alkanes 
bending) and C-O (alkoxy stretching) vibrations are similar 
in the treated sample compared with the control sample 
(Table 2, entry 7). 
Table 2. FT-IR data of the control and Biofield Energy Treated W. somnifera (ashwagandha) root extracts.  
Entry No.  Mode of vibration 
Characteristic absorption (s) of ashwagandha root extract (cm-1) 
Control  Trivedi Effect®
 
Treated  
1 O-H stretching 3392 3367 
2 C-H alkanes stretching 
2927 2927 
2856 2856 
3 C=O stretching (α, β-unsaturated ketone) 1683 1684 
4 C=C aromatic Bending 1515 1515 
5 C-H alkanes bending 
1464 1460 
1385 1398 
6 C-O stretching carboxylic acid 1291 1268 
7 C-O in alkoxy stretching 
1127 1127 
1033 1037 
8 C-H aromatic bending 617 618 
 
Altogether, FT-IR results suggested that the force constant 
of O-H (stretching), and C-O (stretching) functional groups 
of the phytoconstituents present in the treated ashwagandha 
root extract were reduced compared with the control sample. 
Hence, it is assumed that The Trivedi Effect® treatment 
might be responsible for changing the structural features of 
the phytoconstituents present in the ashwagandha root 
powder extract. 
3.4. Ultra Violet-Visible Spectroscopy (UV-Vis) Analysis 
The UV-visible spectra of the control and The Trivedi 
Effect® treated ashwagandha root extract are shown in Figure 
4. The wavelength for the maximum absorbance (λmax) of the 
both the control and treated ashwagandha root extract were at 
205.4 and 205.6 nm, respectively. There was a minor shift of 
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absorbance maxima from the control sample (1.8559) to the 
treated sample (1.8361). It has been reported that the 
wavelength for the maximum absorbance for the 
ashwagandha root extract was at 208.50 nm [55]. However, 
no significant change in the λmax of the treated sample was 
observed compared with the control sample. It is reported 
that the UV absorbance occurred due to excitation of 
electrons from highest energy occupied molecular orbital 
(HOMO) to lowest energy unoccupied molecular orbital 
(LUMO) [56]. It indicated that energy gap between the 
HOMO and LUMO in the treated sample was similar 
compared with the control sample. 
 
Figure 3. FT-IR spectra of the control and Biofield Energy Treated W. somnifera (ashwagandha) root extract. 
 
Figure 4. UV-vis spectra of the control and Biofield Energy Treated W. somnifera (ashwagandha) root extract. 
Table 3. Thermal degradation steps of the control and Biofield Energy Treated W. somnifera (ashwagandha) root extract.  
S. No. 
Temperature (°C) % Weight loss 
% Changea 
Control Treated Control Treated 
1st step of degradation 202.62 201.85 10.51 10.49 -0.19 
2nd step of degradation 448.29 454.47 57.69 58.74 1.82 
3rd step of degradation 895.61 896.12 17.02 17.22 1.18 
a denotes the percentage change in the weight loss of Biofield Energy Treated sample with respect to the control sample. 
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3.5. Thermogravimetric Analysis (TGA) 
The TGA thermograms of both the control and treated 
samples showed the three steps of thermal degradation 
(Figure 5) and the results are mentioned in Table 3. The 
control sample lost weight about 10.51%, 57.69%, and 
17.02% in the 1st, 2nd, and 3rd steps of degradation, 
respectively from its original weight. Similarly, the treated 
sample lost weight about 10.49%, 58.74%, and 17.22% in 
the three steps of degradation from its original total weight. 
The total mass loss in the control and treated sample was 
85.22%, and 86.45%, respectively. The total weight loss 
was increased by 1.44% in the case of the treated sample 
compared with the control sample. The current study 
showed there was a decrease in the thermal stability of the 
treated ashwagandha compared with the control sample. 
3.6. Differential Scanning Calorimetry (DSC) Analysis 
Measurement of the melting point and latent heat of fusion 
was performed using DSC analysis (Figure 6. and Table 4). The 
DSC thermograms of the control and treated samples revealed 
the sharp endothermic inflection at 96.71°C and 91.08°C 
respectively, which was due to the evaporation of the bounded 
water molecule present in the sample. However, the control and 
treated ashwagandha indicated the endothermic peak at 
203.43°C and 201.67°C, respectively. Several small 
endothermic peaks also observed in the thermograms of both in 
the control and treated samples, which may be due to the 
multiple phytoconstituents present in the ashwagandha root 
extract in a very small concentration [57, 58]. The analysis 
revealed that there was a lowering of the melting point by 0.87% 
of the treated sample than the control sample. 
Table 4. The melting point (°C) and latent heat of fusion (J/G) values of the control and Biofield Energy Treated W. somnifera (ashwagandha) root extract.  
Sample 
Enthalpy of decomposition 
(∆H) J/g 
Onset melting temperature 
(Tonset) °C 
Peak melting temperature 
(Tpeak) °C 
Endset melting 
temperature (Tendset) °C 
Control  8.66 197.97 203.45 221.37 
Trivedi Effect® Treated 6.77 200.23 201.67 214.13 
% Changea -21.82 1.14 -0.87 -3.27 
Tonset:
 Onset melting temperature, Tpeak: Peak melting temperature, Tendset: Endset melting temperature, ∆H: Latent heat of fusion, 
a denotes the percentage 
change of Biofield Energy Treated sample with respect to the control sample. 
 
Figure 5. The TGA thermograms of the control and Biofield Energy Treated W. somnifera (ashwagandha) root extract. 
 
Figure 6. DSC thermograms of the control and Biofield Energy Treated W. somnifera (ashwagandha) root extract. 
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The latent heat of fusion (∆H) of the treated (6.77 J/g) 
sample was significantly decreased by 21.82% compared 
with the control (8.67 J/g) sample. The results indicated that 
the treated ashwagandha needed the less latent heat of fusion 
compared with the control sample for the process of melting. 
It is anticipated from the thermal analysis that The Trivedi 
Effect® - Energy of Consciousness Healing Treatment might 
alter the stored potential energy of the ashwagandha root 
extract which may lead to the reduction in the melting point 
and latent heat of fusion (∆H), which may influence the 
volatility of the ashwagandha root extract. Since the sample 
has to be in the vapour phase to be transported, Gas 
Chromatography is advantageous to thermally volatile 
compounds [59, 60]. Hence, the treated sample would be 
more advantageous in the chromatography point of view for 
the better metabolite profiling of ashwagandha root extract 
by the Gas Chromatography-Mass spectroscopy (GC-MS). 
4. Conclusions 
The current research work revealed that The Trivedi 
Effect® - Energy of Consciousness Healing Treatment 
(Biofield Energy Healing) Treatment has the outstanding 
capability for the reduction of the particle size, along with 
enhanced surface area and altered the thermal properties of 
W. somnifera (ashwagandha) root extract. The PXRD 
analysis exhibited that both the control and treated samples 
were amorphous in nature. The particle size at d10 and d50 
values of the treated sample were decreased by 4.66% and 
6.02% and at d90 slightly increased by 0.99% compared with 
the control sample The average surface area of the treated 
(0.130 m2/g) sample was increased by 4.84% compared 
with the control (0.124 m2/g) sample. The FT-IR results 
suggested that the force constant of O-H (stretching), and 
C-O (stretching) functional groups of the phytoconstituents 
present in the treated ashwagandha root extract were 
reduced compared with the control sample. The UV-vis 
analysis revealed that the wavelength for the maximum 
absorbance of the control and treated samples were at 205.4 
and 205.6 nm, respectively. The TGA thermograms 
exhibited three steps of the degradation process, and the 
total weight loss of the treated (86.45%) sample was 
increased by 1.44% compared with the control (85.22%) 
sample. The DSC analysis revealed that the melting point of 
the treated (201.67) sample was reduced by 0.87% 
compared with the control (203.43°C) sample. The latent 
heat of fusion of the treated (6.77 J/g) sample was 
significantly decreased by 21.82% compared with the 
control (8.67 J/g) sample. Hence, the treated ashwagandha 
root extract could be more soluble, absorbable from the gut 
and more bioavailable compared with the untreated 
compound and be more suitable for any type of oral 
pharmaceutical and nutraceutical formulation which might 
be providing better therapeutic response against various 
diseases such as diabetes mellitus, allergies and septic 
shock; stress-related disorders like sleep disorder, insomnia, 
anxiety, depression, Attention Deficit Disorder (ADD), 
Attention Deficit Hyperactive Disorder (ADHD), mental 
restlessness (mind chattering), brain frog, low libido, 
impotency, lack of motivation, mood swings, fear of the 
future, confusion, migraines, headaches, forgetfulness, 
overwhelm, loneliness, worthlessness, indecisiveness, 
frustration, irritability, chronic fatigue, 
obsessive/compulsive behavior and panic attacks; 
inflammatory diseases and immunological disorders like 
Lupus, Systemic Lupus Erythematosus, Hashimoto 
Thyroiditis, Type 1. Diabetes, Asthma, Chronic peptic 
ulcers, Tuberculosis, Hepatitis, Chronic active hepatitis, 
Celiac Disease (gluten-sensitive enteropathy), Addison 
Disease, Crohn's disease, Graves’ Disease, Pernicious and 
Aplastic Anemia, Sjogren Syndrome, Irritable Bowel 
Syndrome (IBS), Multiple Sclerosis, Rheumatoid arthritis, 
Chronic periodontitis, Ulcerative colitis, Chronic sinusitis, 
Myasthenia Gravis, Atherosclerosis, Vasculitis, Dermatitis, 
Diverticulitis, Rheumatoid Arthritis, Reactive Arthritis, 
Alopecia Areata, Psoriasis, Scleroderma, Fibromyalgia, 
Chronic Fatigue Syndrome and Vitiligo; aging-related 
diseases like cardiovascular disease, arthritis, cancer, 
Alzheimer’s disease, dementia, cataracts, osteoporosis, 
diabetes, hypertension, glaucoma, hearing loss, Parkinson’s 
Disease, Huntington’s Disease, Prion Disease, Motor 
Neurone Disease, Spinocerebellar Ataxia, Spinal muscular 
atrophy, Amyotrophic lateral sclerosis, Friedreich’s Ataxia, 
Lewy Body Disease, chronic infections and many more. 
Abbreviations 
DSC: Differential scanning calorimetry, FT-IR: Fourier 
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